Affiliation:
1. Republican Research and Practical Center for Epidemiology and Microbiology
Abstract
Relevance. Serological studies play an important role in assessing the spread of SARS-CoV-2 and formation of post-infection and post-vaccination immune response.The Aims aim of the study was a comparative assessment of seroprevalence and concentration of antibodies to SARS-CoV-2 at 3–6 months after infection or vaccination.Materials & Methods. For the presence of total IgM and IgG antibodies to RBD fragment of the SARS-CoV-2 S protein, the blood sera of 1331 people aged 18-70 years were examined, of which 334 had COVID-19 3–6 months before the study, 305 did not have COVID-19 and were vaccinated (using Sputnik V, Russia, or Sinopharm, PRC) 3–6 months before the study, 692 people were not ill and were not vaccinated. A quantitative assessment of IgG antibodies to the full-size S-protein of SARS-CoV-2 was performed for 435 samples.Results. The proportion of seropositive individuals 3–6 months after COVID-19 or after vaccination did not differ: 92.5% and 93.8% of the corresponding group had antibodies. Among the non-ill and unvaccinated, 45.7% also had specific antibodies, which indicates a high level of asymptomatic infection with SARS-CoV-2. The group of vaccinated was also examined immediately before the introduction of the vaccine, and 39.7% of them already had specific antibodies due to asymptomatic infection with SARS-CoV-2. The median concentration of antibodies in the group of COVID-19 was statistically significantly higher than in asymptomatically infected (50.9 AE/ml versus 29.1 AE/ml). The largest proportion of seropositive individuals (100.0%) and the highest concentration of antibodies (110 AE/ml) were detected in the group of vaccinated who had pre-existing antibodies.Conclusion. Infection with the SARS-CoV-2 is characterized by a high frequency of subclinical course. Asymptomatic infection induced a weaker immune response compared to symptomatic COVID-19 or vaccination. Hybrid immunity caused by natural infection with SARS-CoV-2 and subsequent vaccination was the most persistent and pronounced.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology
Reference19 articles.
1. Sharma, A. Farouk I.A., Lal S.K. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13(2):202. doi: 10.3390/v13020202.
2. Krammer F., Simon V. Serology assays to manage COVID-19. Science. 2020;368(6495):1060–1061.
3. Alter G., Seder R. The power of antibody-based surveillance. New England Journal of Medicine. 2020;383(18):1782–1784.
4. Margiotti K., Fabiani М., Mesoraca, A., Giorlandino C. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol. 2021; 65(4):333–338. doi: 10.4149/av_2021_401.
5. Iyer A.S., et al. Persistence and decay of human antibody responses to the receptor bindin domain of SARS-CoV-2 spike protein in COVID-19 patients. Science immunology. 2020; 5( 52):eabe0367.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献